Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed IRO®, a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments.
By fully automating and standardizing CGT manufacturing in a closed platform, IRO® enables you to quickly scale from from R&D into the clinic, and from the clinic to commercial-scale manufacturing.
So, complex manufacturing challenges can be put where they belong – in the past.
PODCASTS AND VIDEOS
Addressing Core Requirements In CGT Manufacturing Optimization
Discover how a fully automated, standardized approach can enhance biological performance, reduce process timelines, and enable commercial-scale production for cell and gene therapy treatments.
Ori Spotlight: Building Early-Phase CGT Infrastructure For Translational Success
Tighter integration between research, process development, and manufacturing is key to accelerating the translation of cell therapies from the lab to the clinic. Learn how a leading academic center is doing it.
Accelerating CGT Scale-Up With An Advanced Manufacturing Platform
By exploring the integration of advanced manufacturing platforms, you can discover how to improve biological performance and leverage the economic and operational benefits of closed systems.
How Smart Planning Helps CGT Scale Further, Faster
Henrik Anderson, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, explores how early planning, automation, and economic discipline can help scale the impact of cell therapies.
Ori Spotlight: Investor Confidence In Advanced Therapies Is Critical For Long-Term Success
Endpoints News founder Arsalan Arif shares his journey and unpacks the cell and gene therapy market, from investor sentiment to the challenges of scaling innovation.
Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access
A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.
Ori Spotlight: Designing Scalable Cell Therapy Manufacturing From Day One (Part Two)
Aaron Vernon from Quell Therapeutics joins to explore building robust cell therapy manufacturing, focusing on overcoming bottlenecks, smart facility design, and the crucial role of digitalization.
Ori Spotlight: Designing Scalable Cell Therapy Manufacturing From Day One (Part One)
Discover how to build robust, scalable systems and improve throughput with insights from Quell Therapeutics' Chief Manufacturing Officer, Aaron Vernon.
Enabling Widespread Access To Life Saving Cell And Gene Therapies
Explore how rethinking the manufacturing process for cell therapies can accelerate development and commercialization, ultimately benefiting patients waiting for these life-saving treatments.
CONTACT INFORMATION
Ori Biotech
3675 Market St, Suite 200
Philadelphia, PA 19204
UNITED STATES
SOLUTIONS
IRO: The New Standard Of CGT Manufacturing
Experience a new standard in cell and gene therapy production. Achieve faster processing, higher yields, and reduced costs with a closed, automated solution built to scale your innovations.
FEATURED INSIGHTS
-
![Contamination Risk Mitigation In Cell Culture Media]( "Scalability: Consistent And Reproducible Manufacturing Across A Multi-Unit System")
A study demonstrates consistent manufacturing of T cells across a multi-unit system, with low variability in key metrics like cell expansion and transduction efficiency.
-
![GettyImages-2189138619 lab]( "Automating Cell Therapy Manufacturing And Enabling Rapid Multi-Site Tech Transfer")
Find out how automating cell therapy manufacturing with a flexible platform can improve biological performance, streamline tech transfer, and support regulatory confidence for scalable, multi-site production.
-
![GettyImages-2183428964 lab]( "Automation In CAR-T Cell Manufacturing")
Discover how to achieve superior CAR-T cell yields and expedite production with an automated platform that provides flexible mixing modes and continuous monitoring for enhanced manufacturing efficiency.
-
![GettyImages-1317697237-CAR-T-Cells-Therapy]( "Mixing Modes In IRO® For CAR-T Manufacturing")
Unlock superior cell and gene therapy manufacturing with IRO's novel bioreactor geometry and flexible operating parameters for optimal control.
-
![Ori Biotech - IRO]( "Combining Best-Of-Breed Tech And Services To Ensure Commercial Success")
Current "end-to-end" automation often forces sacrifices in cell therapy manufacturing, but a strategy integrating specialized technologies for key bottlenecks is now aiming to improve efficiency.
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "Transforming The Status Quo In Cell Therapy Manufacturing")
Explore data-driven advancements in cell therapy manufacturing and learn how focusing on biology first can lead to more robust and scalable manufacturing solutions.
-
![Ori Biotech - reducing CAR-T manufacturing costs]( "Reducing CAR-T Manufacturing Costs And Duration")
Addressing critical hurdles in CAR-T cell production, this research demonstrates methods to enhance efficiency and reduce expenses for broader patient benefit.
